Christopher Gaeta

Christopher Gaeta has a diverse work experience in the healthcare and life sciences industries. In 2018, they worked as a Clinical Researcher at the Children's Hospital of Philadelphia, where they focused on emergency medicine and gastrointestinal research. Christopher then moved on to become a Business Operations Consultant at Lemonaid Health in 2020. Later that year, they joined VU Venture Partners as a Venture Capital Associate, specializing in healthcare investments. In 2021, Gaeta became the Chief Executive Officer of Grapefruit, a position they held until 2022. Christopher also served as an Advisor for Sonara Health starting in 2021. Currently, Gaeta is the Founder and Chief Executive Officer of InSite Health, a role they assumed in 2022. Additionally, they have been serving as a Strategic Advisor for Prysm Institute since 2020, supporting their life sciences incubator and global accelerator initiatives.

Christopher Gaeta has a background in neuroscience and medical ethics from the University of Pennsylvania School of Medicine. Christopher also holds a Bachelor of Science degree in Economics from Swarthmore College. In 2019-2020, they pursued studies in innovation and entrepreneurship at Stanford University. Additionally, they attended The Taft School but the field of study is unknown. Christopher has obtained certifications in COVID-19 Public Health Strategy from the Pennsylvania Emergency Management Agency, Bloomberg Market Concepts from Bloomberg LP, and Emergency Medicine Technician from the National Registry of Emergency Medical Technicians. Christopher has also obtained certifications in HIPAA, Privacy, and Data Protection from the Children's Hospital of Philadelphia Research Institute, as well as Incident Command Systems, ICS-100 from FEMA.